Biología molecular del carcinoma vesical

Archivos Espanoles de Urologia

Volumn 50, Issue 8, 1997, Pages 855-866

  Sierra, Jesús Moreno ^a   Maestro De Las Casas, Ma Luisa ^a   Almarza, Javier Chicharro ^a   Heredia, Ma Dolores Ortega ^a   García Asenjo, José López ^a   Sánchez, Concepción Merino ^a   Jiménez, Enrique Blanco ^a   Silmimoyano, Ángel ^a   Estévez, L Resel ^a  

^a HOSPITAL CLÍNICO SAN CARLOS   (Spain)

Author keywords

[No Author keywords available]

Indexed keywords

EPIDERMAL GROWTH FACTOR; EPIDERMAL GROWTH FACTOR RECEPTOR 2; ONCOPROTEIN; PROTEIN P53;

AGED; ARTICLE; BLADDER; BLADDER TUMOR; CANCER STAGING; CHEMISTRY; COMPARATIVE STUDY; FEMALE; GENE EXPRESSION REGULATION; GENETICS; HUMAN; MALE; MIDDLE AGED; MORTALITY; PATHOLOGY; PROGNOSIS; TRANSITIONAL CELL CARCINOMA; UROTHELIUM;

AGED; AGED, 80 AND OVER; CARCINOMA, TRANSITIONAL CELL; EPIDERMAL GROWTH FACTOR; FEMALE; GENE EXPRESSION REGULATION, NEOPLASTIC; HUMANS; MALE; MIDDLE AGED; NEOPLASM STAGING; ONCOGENE PROTEINS V-ERBB; PROGNOSIS; RECEPTOR, ERBB-2; TUMOR SUPPRESSOR PROTEIN P53; URINARY BLADDER; URINARY BLADDER NEOPLASMS; UROTHELIUM;

EID: 2542590066     PISSN: 00040614     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (67)

1. SAGER, R.: "Tumor suppressor genes: "The puzzle and the promise." Science, 246: 1.406, 1989.
2. O'DONNELL, M. EDITORIAL: "Transitional cell carcinoma-tantalizing issues of tumor biology." J. Urol., 156: 961, 1996.
3. MORENO SIERRA, J.; GÓMEZ RUIZ, J. J.; ORTEGA HEREDIA, M. D. y cols.: "Conceptos básicos en la utilización de marcadores tumorales en el diagnóstico y seguimiento de los tumores vesicales malignes." Arch. Esp. Urol., 46: 187, 1993.
4. RESEL, L. y MORENO, J.: "Fundamentos fisiopatológicos y clínicos de los marcadores tumorales en uro-oncología." Pulso, 1994.
5. MERINO, C.: "Caracterización biológica del carcinoma vesical: expresión de p53. EGFR y oncogen retrovírico erbB-2/neu." Tesis doctoral, Universidad Complutense. Madrid, 1995.
6. KLEIN, G. y KLEIN, E.: "The origin of human cancers." Nature, 315: 190, 1985.
7. SCHECHETER, A. L.; STEM, D. F.; VAIDYANATHAN, L. y cols.: "The neu oncogene: an erbB-related gene encoding a 185,000 tumor antigen." Nature, 312: 513, 1984.
8. SLAMON, D. J.; GODOLPHIN, W.; JONES, L.: "Studies of HER-2/neu proto-oncogene in breast and ovarian cancer." Science, 244: 707, 1989.
9. YONEMURA, Y.; NINOMTYA, I.; OHOYAMA, S.: "Expression of c-erbB-2 oncopretein in gastric carcinoma: immunoreactivity for c-erbB-2 protein is an independent indicator of poor short-term prognosis in patients with gastric carcinoma." Cancer, 67: 2.914, 1991.
10. MORIYAMA, M.: MORISHITA, Y.; MORI, S. y cols.: "Ultrastructural localization of c-erbB-2 gene product in transitional cell carcinoma of the urinary tract." Ultrastruct. Pathol., 14: 339, 1990.
11. MORIYAMA, M.; AKIYAMA, T.; YAMAMOTO, T.: "Expression of c-erB-2 gene product in urinary bladder cancer." J. Urol., 145: 423, 1991.
12. ZHAU, H.; ZHANG, X.; VON ESCHEMBACH, A.: "Amplification and expression of the c-erbB-2/neu proto-oncogene in human bladder cancer." Mol. Carcinog., 3: 254, 1991.
13. WEINBERG, R. A.: "Ras oncogenes and the molecular mechanisms of carcinogenesis." Blood, 64: 1.143, 1984.
14. MORENO SIERRA, J.; MAESTRO DE LAS CASAS, M.: ORTEGA HEREDIA, M. y cols.: "Dosificación cuantitativa del receptor urotelial del factor de crecimiento epidérmico (EGFR) en carcinomas vesicales superficiales e invasivos." Actas Urol. Esp., 18: 215, 1994.
15. COOMBS, L.; PIGOTT, D.; SWEENEY, E.: "Amplification and over-expression of c-erbB-2 in transitional cell carcinoma of the urinary bladder." Br. J. Cancer, 63: 601, 1991.
16. MESSING, E.: "Growth factors in human bladder tumours." J. Urol., 131: 111, 1984.
17. GANNON, L.; LANE, D.: "Protein synthesis required to nuclear a mutant p53 protein which is temperature sensitive for nuclear transport." Nature. 349: 802, 1991.
18. LANE, D.; CRAWFORD, L.: "T antigen is bound to host protein in SV40 transformed cell." Nature., 278: 261, 1979.
19. WRIGHT, C.; MELLON, K. J.; JOHNSTON, P. y cols.: "Expression of mutant p53, c-erbB2 and epidermal growth factor receptor in transitional cell carcinoma of the human urinary bladder." Br. J. Cancer., 63: 967, 1991.
20. REICH, N.; LEVINE, A.: "Growth regulation of a cellular tumour antigen, p53, in non transformed cells." Nature, 308: 199, 1984.
21. FINLAY, C.; HINDS, P.; LEVINE, A.: "P53 proto-oncogene can act as a suppressor of transformation." Cell, 57: 1.083, 1989.
22. VOGELSTEIN, B.; KINZLER, K.: "P53 function and dysfunction." Cell, 70: 523, 1992.
23. JENKINS, J.; RUDGE, K.; CURRIE, G.: "Cellular immortalization by acDNA clone encoding the transformation associated phosphoprotein p53." Nature, 313: 651, 1984.
24. BENCHIMOL, S.: "Immortalization of rat embryon fibroblast by the celullar p53 oncogene." Oncogen, 2: 445, 1988.
25. NIGRO, J.; BAKER, S.; PREINGER, A. y cols.: "Mutation in the p53 gene occur in diverse human tumour types." Nature, 342: 705, 1989.
26. VOGELSTEIN, B.: "Cancer: a deadly inheritance." Nature, 348: 681, 1990.
27. SLAMON, D. J.; PLARQ, G. M.; WONG, S. G. y cols.: "Human breast cancer: correlation of relapse and survival with amplification of HER-2/NEU oncogene." Science, 235, 177, 1987.
28. FOSSA, S.; BERNER, A.; JACOBSEN, A. y cols.: "Clinical significance of DNA ploidy and S-phase fraction and their relation to p53 protein, c-erb-B2 protein in operable muscle-invasive bladder cancer." Br. J. Cancer, 68: 572, 1993.
29. WOLF, D.; HARRIS, N.; ROTTER, V.: "Reconstitution of p53 expression in a non producer Ab-MuLV transformed cell line by transfection of a functional p53 gene." Cell, 38: 199, 1984.
30. LUTZEYER, W.; RUBBEN, H.; DAHM, H.: "Prognostic parameters in superficial bladder cancer. An analysis of 315 cases." J. Urol., 127: 250, 1982.
31. POCOCH, R.; PONDER, B.; O'SULLIVAN: Prognostic factors in nhon-infiltating carcinoma of the bladder: A preliminary report." Br. J. Urol., 54: 711, 1982.
32. NAKAPOULOU, L.; CONSTANTINIDES, G.' PAPAN-DROPOULOS, J. y cols.: "Evaluation of over-expression of p53 tumor suppressor protein in cancer: comparison with DNA ploidy." Urology, 46: 334, 1995.
33. BORLAND, R.; BRENDLER, C.; ISAACS, W.: "Molecular biology of bladder cancer." Hematol. Oncol. Clin. North Am., 6: 31, 1992.
34. CATTORETT, G.; RILKE, F.; ANDREOLA, S.: "P53 expression in breast cancer." Int. J. Cancer, 41: 178, 1988.
35. MESSING, E.: "Growth factors and human bladdei tumors." J. Urol., 131: 111, 1984.
36. WEE, A.; TEHJRAIJU, G.: "Clinical importance of p53 protein in bladder carcinoma and its precursor lesions." J. Clin. Pathol., 47: 453, 1994.
37. YE, D.; ZHENG, J.; QIIAN, S. y cols.: "Expression of p53 product in Chinese human bladder carcinoma." Urol. Res., 21: 223, 1993.
38. SARKIS, A., DALBAGNI, G.; CORDON, C.: "Nuclear overexpression of p53 protein in transitional cell bladder cancer: a marker for disease progression." J. Nat Cancer Inst., 85: 53, 1993.
39. SARKIS, A.; DALBAGNI, G.; CORDON, C. y cols.: "Association of p53 gene nuclear overexpression and tumor progression in carcinoma in situ of the bladder." J. Urol., 152: 388, 1994.
40. KUCZYK, M.; SERTH, J.; HERVATIN, C. y cols.: "Detection of p53 tumor-suppressor gene protein in bladder tumors and prostate cancer: possible clinical implications". World J. Urol., 12: 345, 1994.
41. KAMEL, D.; SOIMI, Y.; NUORVA, K. y cols.: "P53 and c-erbB2 expression in schistosomal urinary bladder carcinoma and schistosomal cystitis with premalignant lesions." Virchows Arch., 424: 349, 1994.
42. MORENO SIERRA, J.; MAESTRO DE LAS CASAS, M.; ORTEGA HEREDIA, M. D. y cols.: "Dosificación cuantitativa del receptor urotelial del factor de crecimiento epidérmico (EGFR) en carcinomas vesicales superficiales e invasivos." Actas Urol., 18: 215, 1994.
43. FUJIMOTO, K.; YAMADA, Y.; OKAJIMA, E. y cols.: "Frequent association of p53 gene mutation in invasive bladder cancer." Cancer Res., 52: 1.393, 1992.
44. GOUSTIN, A. S.; LEOF, E. B.; SHIPLEY, G. y cols.: "Growth factors and cancer." Cancer Res., 46: 1.015, 1986.
45. ABAD, A.; VEGH, I.; COSTAS, P. y cols.: "El receptor del factor de crecimiento epidérmico en el cáncer de mama." Cirugía Esp., 52: 22, 1992.
46. ABAD, A.; VEGH, I.; CASSINELLO, J. y cols.: "El receptor del factor de crecimiento epidérmico en el cáncer de mama avanzado." Cirugía Esp., 52: 109, 1992.
47. VALLADARES, Y.: "Biología molecular de los cánceres urológicos." En: Resel, L y Moreno, J. Fundamentos fisiopatológicos y clínicos de los marcadores tumorales en uro-oncología. Ed. Pulso, 1994.
48. COHEN, S.: "The epidermal growth factor." Cancer, 51: 1.787, 1983.
49. SMITH, K.; FENNELLY, J. A.; NEAL, D. E. y cols.: "Characterization and quantitation of the epidermal growth factor receptor in invasive and superficial bladder tumors." Cancer Res., 49: 5.810, 1989.
50. WRIGHT, C.; MELLON, K.; JOHNSTON, P y cols.: "Expression of mutant p53, c-erbB2 and epidermal growth factor receptor in transitional cell carcinoma of the urinary bladder." Br. J. Cancer, 63: 967, 1991.
51. NEAL, D. E.; BENNET, M.; HALL, R. y cols.: "Epidermal growth factor receptor in human bladder cancer: comparison of invasive and superficial tumors." Lancet, 16: 366, 1985.
52. GOMELLA, L.; ANGLARD, P.; SARGENT, E. y cols.: "Epidermal growth factor receptor gene analysis in renal cell carcinoma." J. Urol., 143: 191, 1990.
53. NEAL, D.; MELLON, K.: "Epidermal growth factor receptor and bladder cancer: a review." Urol. Int., 48: 365, 1992.
54. WOOD, D. P.; FAIR, W. R. y CHAGANTI, R. S.: "Evaluation of epidermal growth factor receptor DNA amplification and mmRNA expression in bladder cancer." J. Urol., 147: 274, 1992.
55. HARNEY, S.; LIEBERT, M.; WEDEMEYER, G. y cols.: "The expresion of epidermal growth factor receptor on human bladder cancer: potential use in radioimmmonoscintigraphy." J. Urol., 146: 227, 1991.
56. NEAL, D. E.; SHARPLES, L.; SMITH, K. y cols.: "The epidermal growth factor receptor and the prognosis of bladder cancer." Cancer, 65: 1.619, 1990.
57. HERNÁNDEZ, M.: "Manual molecular del cancer." Págs. 55-56. Ed. MCR, 1992.
58. WEINER, D.; NORDBERG, J.; ROBINSON, R. y cols.: "Expression of the neu gene encoded protein (p185) in human non-small cell carcinomas of lung." Cancer Res., 50: 421, 1990.
59. SHI, D.; HE, G.; CAO, S.: "Overexpression of the c-erbB-2/neu encoded p185 protein in primary lung cancer." Mol. Carcinog., 5: 213, 1992.
60. MORIYAMA, M.; AKIYAMA, T.; YAMAMOTO, T.: "Expression of c-erbB-2 gene product in urinary bladder cancer." J. Urol., 145: 423, 1991.
61. GU, F.; SHEN, J.; ZHOU, A. y cols.: "Amplification and expression of the c-erbB-2 and c-myc proto-oncogenes in bladder and renal carcinoma." En: Olsson, C. (ed.) Oncogene and Molecular Genetics of Urological Tumors. Churchill Livingstone. Edinburgh, págs. 103-110, 1992.
62. WOOD, D.; WARTIN, D.; REUTER, V. y cols.: "DNA, RNA and immunohistochemical characterization of the HER-2/neu oncogene in transitional cell carcinomma of the bladder." J. Urol., 146: 1.398, 1992.
63. NAKOPOULOU, L.; ZERVAS, A.; ZOLOTA, V. y cols.: "Immunohistochemical expression of epidermal growth factor receptor and protooncogene c-erbB2 in transitional cell carcinoma of the bladder." En: Olsson, C. (ed.). Oncogene and Molecular Genetics of Urological Tumors. Churchill Livingstone. Edinburgh, 1992.
64. SLAMON, D.; GODOLPHIN, W.; JONES, L. y cols.: "Studies of the HER-2/neu protooncogenes in human breast and ovarian cancer." Science, 244: 707, 1989,
65. KRISTENSEN, J.; LOSE, G.; LUND, F. y cols.: "Epidermal growth factor in urine from patients with urinary bladder tumors." Eur. Urol., 14: 313, 1988.
66. YE, D.; ZHENG, J.; QIAN, S. y cols.: "Expresion of p53 products in Chinese human bladder carcinoma." Urol. Res., 21: 223, 1993.
67. WRIGHT, C.; MELLON, K.; JOHNSTON, P. y cols.: "Expression of mutant p53, c-erbB-2 and the epidermal growth factor receptor in transitional cell carcinoma of the urinary bladder." Br. J. Cancer, 62: 764, 1990.